Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K

Bone

Volumn 26, Issue 4, 2000, Pages 367-373

  Sassi, M L ^a   Eriksen, H ^a   Risteli, L ^a   Niemi, S ^b   Mansell, J ^c   Gowen, M ^d   Risteli, J ^a  

^a UNIVERSITY OF OULU   (Finland)

^b Orion Diagnostica Oy   (Finland)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Antigenic determinant; Bone collagen degradation; Bone marker; Carboxyterminal telopeptide of human type I collagen (ICTP); Cathepsin K; Matrix metalloproteinase 9 (MMP 9)

Indexed keywords

CATHEPSIN K; CHYMOTRYPSIN A; COLLAGEN TYPE 1; COLLAGENASE; COLLAGENASE 3; EPITOPE; GELATINASE B; MARKER; PEPTIDE; PHENYLALANINE; RECOMBINANT ENZYME;

AMINO ACID SEQUENCE; ANTIGENICITY; ARTICLE; BONE METASTASIS; CARBOXY TERMINAL SEQUENCE; CATTLE; COLLAGEN DEGRADATION; CONTROLLED STUDY; CROSS LINKING; HUMAN; IMMUNOASSAY; IMMUNOCHEMISTRY; IMMUNOREACTIVITY; OSTEOLYSIS; RHEUMATOID ARTHRITIS;

AMINO ACID SEQUENCE; ANIMALS; BONE AND BONES; CATHEPSINS; CATTLE; CHYMOTRYPSIN; COLLAGEN; COLLAGEN TYPE I; COLLAGENASES; EPITOPES; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 9; MOLECULAR SEQUENCE DATA; PEPTIDES; RADIOIMMUNOASSAY; TRYPSIN;

EID: 0034012685     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(00)00235-0     Document Type: Article

References (28)

1. Aruga A., Kolzumi M., Hotta R., Takahashi S., Ogata E. Usefulness of bone metabolic markers in the diagnosis and follow-up of bone metastasis from lung cancer. Br J Cancer. 76:1997;760-764.
2. Bernard M.P., Chu M.L., Myers J.C., Ramirez F., Eikenberry E.F., Prockop D.J. Nucleotide sequences of complementary deoxyribonucleic acids for the pro alpha 1 chain of human type I procollagen. Statistical evaluation of structures that are conserved during evolution. Biochemistry. 22:1983;5213-5223.
3. Bossard M.J., Tomaszek T.A., Thompson S.K., Amegadzie B.Y., Hanning C.R., Jones C., Kurdyla J.T., McNulty D.E., Drake F.H., Gowen M., Levy M.A. Proteolytic activity of human osteoclast cathepsin K. J Biol Chem. 271:1996;12517-12524.
4. Elomaa I., Virkkunen P., Risteli L., Risteli J. Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. Br J Cancer. 66:1992;337-341.
5. Eriksen E.F., Brixen K., Charles P. New markers of bone metabolism Clinical use in metabolic bone disease [review] . Eur J Endocrinol. 132:1995;251-263.
6. Everts V., Van Der Zee E., Creemens L., Beertsen W. Phagocytosis and intracellular digestion of collagen, its role in turnover and remodeling. Histochem J. 28:1996;229-245.
7. Fietzek P.P., Rexrodt F.W. The covalent structure of collagen. The amino-acid sequence of alpha2-CB4 from calf skin collagen. Eur J Biochem. 59:1975;113-118.
8. Fledelius C., Johnsen A.H., Cloos P.A.C., Bonde M., Qvist P. Characterization of urinary degradation products derived from type I collagen. Identification of a β-isomerized asp-gly sequence within the C-terminal telopeptide (α1) region. J Biol Chem. 272:1997;9755-9763.
9. Foged N.T., Delaisse J.-M., Peng H., Lou H., Sato T., Winding B., Bonde M. Quantification of the collagenolytic activity of isolated osteoclasts by enzyme-linked immunosorbent assay. J Bone Miner Res. 11:1996;226-237.
10. Garnero P., Borel O., Byrjalsen I., Ferreras M., Drake F.H., McQueney M.S., Foged N.T., Delmas P.D., Delaissé J.-M. The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem. 273:1998;32347-32352.
11. Garnero P., Shih W.J., Gineyts E., Karpf D.B., Delmas P.D. Comparison of new biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationship between measurements of the different forms of pyridinoline cross-links. J Clin Endocrinol Metab. 79:1994;1693-1700.
12. Hakala M., Risteli J., Manelius J., Nieminen P., Risteli J. Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis. Ann Rheum Dis. 52:1993;866-869.
13. Hanson D.A., Eyre D.R. Molecular site specificity of pyridinoline and pyrrole cross-links in type I collagen of human bone. J Biol Chem. 271:1996;26508-26526.
14. Hassager C., Risteli J., Risteli L., Christiansen C. Effect of the menopause and hormone replacement therapy on the carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen. Osteopor Int. 4:1994;349-352.
15. Heickendorff L., Zachariae H., Bjerring P., Halkier-Sørensen L., Søndergaard K. The use of serological markers for collagen synthesis and degradation in systemic sclerosis. J Am Acad Dermatol. 32:1995;584-588.
16. Inaoka T., Bilbe G., Ishibashi O., Tezuka K., Kumegawa M., Kokubo T. Molecular cloning of human cDNA for cathepsin K Novel cysteine proteinase predominantly expressed in bone . Biochem Biophys Res Commun. 206:1995;89-96.
17. Knott L., Tarlton J.F., Bailey A.J. Chemistry of collagen cross-linking Biochemical changes in collagen during the partial mineralization of turkey leg tendon . Biochem J. 322:1997;535-542.
18. Kuboki Y., Tsuzaki M., Sasaki S., Liu C.H., Mechanic G.L. Location of the intermolecular cross-links in bovine dentin collagen, solubilization with trypsin and isolation of cross-link peptides containing dihydroxylysinorleucine and pyridinoline. Biochem Biophys Res Commun. 102:1981;119-126.
19. Kuivaniemi H., Tromp G., Chu M.L., Prockop D.J. Structure of a full-length cDNA clone for the prepro alpha 2(I) chain of human type I procollagen. Comparison with the chicken gene confirms unusual patterns of gene conservation. Biochem J. 252:1998;633-640.
20. Kuypers R., Tyler M., Kurth L.B., Jenkins I.D., Horgan D.J. Identification of the loci of the collagen-associated Ehrlich chromogen in type I collagen confirms its role as a trivalent cross-link. Biochem J. 283:1992;129-136.
21. Liesegang A., Sassi M.L., Risteli J., Eicher R., Wanner M., Riond J.L. Comparison of bone resorption markers during hypocalcemia in dairy cows. J Dairy Sci. 81:1998;2614-2622.
22. Nishi, Y., Atley, L., Eyre, D. E., Edelson, J. G., Superti-Furga, A., Yasuda, T., Desnick, R. J., and Gelb, B. D. Determination of bone markers in pycnodysostosis: Effect of cathepsin K deficiency on bone matrix degradation. J Bone Miner Res. In press.
23. Okada Y., Naka K., Kawamura K., Matsumoto T., Nakanishi I., Fujimoto N., Sato H., Seiki M. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase-gelatinase B) in osteoclasts Implications for bone resorption . Lab Invest. 72:1995;311-322.
24. Randall A.G., Kent G.N., Garcia-Webb P., Bhagat C.I., Pearce D.J., Gutteridge D.H., Prince R.L., Stewart G., Stuckey B., Will R.K., Retallack R.W., Price R.I., Ward L. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationship between measurements of the different forms of pyridinoline cross-links. J Bone Miner Res. 11:1996;1176-1184.
25. Ricard-Blom S., Chossegros P., Guerret S., Trepo C., Grimaud J.A., Chevallier M. The carboxy-terminal cross-linked telopeptide of type I collagen (ICTP) is a potential serum marker of ongoing liver fibrosis. Clin Chim Acta. 248:1996;187-195.
26. Risteli J., Elomaa I., Niemi S., Novamo A., Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen A new serum marker of bone collagen degradation . Clin Chem. 39:1993;635-640.
27. Risteli L., Risteli J. Analysis of extracellular matrix proteins on biological fluids. Meth Enzymol. 145:1987;391-411.
28. Risteli, J. and Risteli, L. Products of bone collagen metabolism. In: Seibel, M. J., Robins, S. P., and Bilezikian, J. P., Eds. Dynamics of bone and cartilage metabolism: Principles and clinical application. London: Academic; 275-287; 1999.